Pirfenidone for treating idiopathic pulmonary fibrosis: an evidence review group perspective of a NICE single technology appraisal

Davis, S. orcid.org/0000-0002-6609-4287, Rafia, R. orcid.org/0000-0002-6914-1990, Carroll, C. orcid.org/0000-0002-6361-6182 et al. (2 more authors) (2019) Pirfenidone for treating idiopathic pulmonary fibrosis: an evidence review group perspective of a NICE single technology appraisal. Pharmacoeconomics, 37. pp. 763-775. ISSN 1170-7690

Abstract

Metadata

Item Type: Article
Authors/Creators:
Copyright, Publisher and Additional Information:

© 2018 Springer Nature Switzerland AG. This is an author produced version of a paper subsequently published in PharmacoEconomics. Uploaded in accordance with the publisher's self-archiving policy. The final publication is available at Springer via https://doi.org/10.1007/s40273-018-0727-1.

Dates:
  • Published: 1 June 2019
  • Published (online): 22 October 2018
Institution: The University of Sheffield
Academic Units: The University of Sheffield > Faculty of Medicine, Dentistry and Health (Sheffield) > School of Health and Related Research (Sheffield) > ScHARR - Sheffield Centre for Health and Related Research
Depositing User: Symplectic Sheffield
Date Deposited: 31 Oct 2018 15:05
Last Modified: 09 May 2024 10:25
Status: Published
Publisher: Springer
Refereed: Yes
Identification Number: 10.1007/s40273-018-0727-1
Related URLs:
Open Archives Initiative ID (OAI ID):

Export

Statistics